Table of Contents

1 Report Overview

• 1.1 Study Scope
• 1.2 Major Manufacturers Covered in This Report
• 1.3 Market Segment by Type
  • 1.3.1 Global Basal Cell Carcinoma Treatment Market Size Growth Rate by Type (2019-2025)
  • 1.3.2 Surgical Excision
  • 1.3.3 Electrodessication & Cutterage
  • 1.3.4 Moh's Surgery
  • 1.3.5 Cryosurgery
• 1.4 Market Segment by Application
  • 1.4.1 Global Basal Cell Carcinoma Treatment Market Share by Application (2019-2025)
  • 1.4.2 Hospitals
  • 1.4.3 Specialty Clinics
  • 1.4.4 Others
• 1.5 Study Objectives
• 1.6 Years Considered

2 Global Growth Trends

• 2.1 Global Basal Cell Carcinoma Treatment Market Size
  • 2.1.1 Global Basal Cell Carcinoma Treatment Revenue 2014-2025
  • 2.1.2 Global Basal Cell Carcinoma Treatment Sales 2014-2025
• 2.2 Basal Cell Carcinoma Treatment Growth Rate by Regions
  • 2.2.1 Global Basal Cell Carcinoma Treatment Sales by Regions 2014-2019
  • 2.2.2 Global Basal Cell Carcinoma Treatment Revenue by Regions 2014-2019
• 2.3 Industry Trends
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers

3 Market Share by Manufacturers

• 3.1 Basal Cell Carcinoma Treatment Sales by Manufacturers
  • 3.1.1 Basal Cell Carcinoma Treatment Sales by Manufacturers 2014-2019
  • 3.1.2 Basal Cell Carcinoma Treatment Sales Market Share by Manufacturers 2014-2019
• 3.2 Revenue by Manufacturers
  • 3.2.1 Basal Cell Carcinoma Treatment Revenue by Manufacturers (2014-2019)
  • 3.2.2 Basal Cell Carcinoma Treatment Revenue Share by Manufacturers (2014-2019)
  • 3.2.3 Global Basal Cell Carcinoma Treatment Market Concentration Ratio (CR5 and HHI)
• 3.3 Basal Cell Carcinoma Treatment Price by Manufacturers
• 3.4 Key Manufacturers Basal Cell Carcinoma Treatment Plants/Factories Distribution and Area Served
• 3.5 Date of Key Manufacturers Enter into Basal Cell Carcinoma Treatment Market
• 3.6 Key Manufacturers Basal Cell Carcinoma Treatment Product Offered
• 3.7 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

• 4.1 Sales and Revenue for Each Type
  • 4.1.1 Surgical Excision Sales and Revenue (2014-2019)
  • 4.1.2 Electrodessication & Cutterage Sales and Revenue (2014-2019)
  • 4.1.3 Moh's Surgery Sales and Revenue (2014-2019)
  • 4.1.4 Cryosurgery Sales and Revenue (2014-2019)
• 4.2 Global Basal Cell Carcinoma Treatment Sales Market Share by Type
• 4.3 Global Basal Cell Carcinoma Treatment Revenue Market Share by Type
• 4.4 Basal Cell Carcinoma Treatment Price by Type

5 Market Size by Application

• 5.1 Overview
• 5.2 Global Basal Cell Carcinoma Treatment Sales by Application

6 United States

• 6.1 United States Basal Cell Carcinoma Treatment Breakdown Data by Company
• 6.2 United States Basal Cell Carcinoma Treatment Breakdown Data by Type
• 6.3 United States Basal Cell Carcinoma Treatment Breakdown Data by Application

7 European Union

• 7.1 European Union Basal Cell Carcinoma Treatment Breakdown Data by Company
• 7.2 European Union Basal Cell Carcinoma Treatment Breakdown Data by Type
• 7.3 European Union Basal Cell Carcinoma Treatment Breakdown Data by Application

8 China

• 8.1 China Basal Cell Carcinoma Treatment Breakdown Data by Company
• 8.2 China Basal Cell Carcinoma Treatment Breakdown Data by Type
• 8.3 China Basal Cell Carcinoma Treatment Breakdown Data by Application

9 Rest of World

• 9.1 Rest of World Basal Cell Carcinoma Treatment Breakdown Data by Company
• 9.2 Rest of World Basal Cell Carcinoma Treatment Breakdown Data by Type
• 9.3 Rest of World Basal Cell Carcinoma Treatment Breakdown Data by Application
• 9.4 Rest of World Basal Cell Carcinoma Treatment Breakdown Data by Countries
  • 9.4.1 Rest of World Basal Cell Carcinoma Treatment Sales by Countries
  • 9.4.2 Rest of World Basal Cell Carcinoma Treatment Revenue by Countries
  • 9.4.3 Japan
  • 9.4.4 Korea
  • 9.4.5 India
  • 9.4.6 Southeast Asia

10 Company Profiles

• 10.1 Sun Pharmaceuticals
  • 10.1.1 Sun Pharmaceuticals Company Details
  • 10.1.2 Company Description and Business Overview
  • 10.1.3 Sales, Revenue and Market Share of Basal Cell Carcinoma Treatment
  • 10.1.4 Basal Cell Carcinoma Treatment Product Introduction
  • 10.1.5 Sun Pharmaceuticals Recent Development
• 10.2 Valeant Pharmaceuticals International
  • 10.2.1 Valeant Pharmaceuticals International Company Details
  • 10.2.2 Company Description and Business Overview
  • 10.2.3 Sales, Revenue and Market Share of Basal Cell Carcinoma Treatment
  • 10.2.4 Basal Cell Carcinoma Treatment Product Introduction
  • 10.2.5 Valeant Pharmaceuticals International Recent Development
• 10.3 Mylan N.V.
  • 10.3.1 Mylan N.V. Company Details
  • 10.3.2 Company Description and Business Overview
  • 10.3.3 Sales, Revenue and Market Share of Basal Cell Carcinoma Treatment
  • 10.3.4 Basal Cell Carcinoma Treatment Product Introduction
  • 10.3.5 Mylan N.V. Recent Development
• 10.4 F. Hoffmann-La Roche Ltd
  • 10.4.1 F. Hoffmann-La Roche Ltd Company Details
  • 10.4.2 Company Description and Business Overview
  • 10.4.3 Sales, Revenue and Market Share of Basal Cell Carcinoma Treatment
  • 10.4.4 Basal Cell Carcinoma Treatment Product Introduction
  • 10.4.5 F. Hoffmann-La Roche Ltd Recent Development
• 10.5 Merck & Co.
  • 10.5.1 Merck & Co. Company Details
  • 10.5.2 Company Description and Business Overview
  • 10.5.3 Sales, Revenue and Market Share of Basal Cell Carcinoma Treatment
  • 10.5.4 Basal Cell Carcinoma Treatment Product Introduction
  • 10.5.5 Merck & Co. Recent Development

11 Value Chain and Sales Channels Analysis

• 11.1 Value Chain Analysis
• 11.2 Sales Channels Analysis
  • 11.2.1 Basal Cell Carcinoma Treatment Sales Channels
  • 11.2.2 Basal Cell Carcinoma Treatment Distributors
• 11.3 Basal Cell Carcinoma Treatment Customers

12 Market Forecast

• 12.1 Global Basal Cell Carcinoma Treatment Sales and Revenue Forecast 2019-2025
• 12.2 Global Basal Cell Carcinoma Treatment Sales Forecast by Type
• 12.3 Global Basal Cell Carcinoma Treatment Sales Forecast by Application
• 12.4 Basal Cell Carcinoma Treatment Forecast by Regions
  • 12.4.1 Global Basal Cell Carcinoma Treatment Sales Forecast by Regions 2019-2025
  • 12.4.2 Global Basal Cell Carcinoma Treatment Revenue Forecast by Regions 2019-2025
• 12.5 United States Market Forecast
• 12.6 European Union Market Forecast
• 12.7 China Market Forecast
• 12.8 Rest of World
  • 12.8.1 Japan
  • 12.8.2 Korea
  • 12.8.3 India

13 Research Findings and Conclusion

14 Appendix

• 14.1 Research Methodology
  • 14.1.1 Methodology/Research Approach
    • 14.1.1.1 Research Programs/Design
    • 14.1.1.2 Market Size Estimation
    • 14.1.1.3 Market Breakdown and Data Triangulation
  • 14.1.2 Data Source
    • 14.1.2.1 Secondary Sources
    • 14.1.2.2 Primary Sources
• 14.2 Author Details

Basal cell carcinoma has a low metastasis rate and is more benign, so it is also called basal cell epithelial tumor. Based on its greater destructiveness, it is also called invasive ulcer. Basal cell carcinoma is more common in the elderly, and it occurs in the head, face, neck and back of the hand, especially the prominent part of the face. It begins with a small nodule that is skin-to-dark-infiltrated, typically waxy, translucent nodules with high curled edges. The central part begins to rupture, with black necrotic sputum, and the central necrosis spreads to the deep tissue, showing large invasive necrosis, which can reach soft tissue and bone tissue.
Among the many treatments, surgical resection is still the most effective treatment for the complete eradication of basal cell carcinoma and avoiding tumor recurrence.
In addition to surgical resection, other methods that can be used to treat basal cell carcinoma include: radiation therapy, photodynamic therapy, scraping electrocautery, cryotherapy, topical application of drugs, etc.
In 2019, the market size of Basal Cell Carcinoma Treatment is 4520 million US$ and it will reach 9090 million US$ in 2025, growing at a CAGR of 9.1% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Basal Cell Carcinoma Treatment.

This report studies the global market size of Basal Cell Carcinoma Treatment, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Basal Cell Carcinoma Treatment sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.

In global market, the following companies are covered:
Sun Pharmaceuticals
Valeant Pharmaceuticals International
Mylan N.V.
F. Hoffmann-La Roche Ltd
Merck & Co.
...

Market Segment by Product Type
Surgical Excision
Electrodessication & Cutterage
Moh's Surgery
Cryosurgery

Market Segment by Application
Hospitals
Specialty Clinics
Others

Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)

The study objectives are:
To analyze and research the Basal Cell Carcinoma Treatment status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Basal Cell Carcinoma Treatment manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

In this study, the years considered to estimate the market size of Basal Cell Carcinoma Treatment are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025